Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026)

Artivion (AORT) reported Liabilities and Shareholders Equity of $883.2 million for Q1 2026, up 11.63% on a YoY basis from $791.2 million in Q1 2025, and little changed quarter-over-quarter from $884.8 million in Q4 2025.

Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Artivion has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $883.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 11.63% year-over-year to $883.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 billion (up 9.17% YoY), and the FY2025 full-year result was $884.8 million, up 12.13% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $883.2 million, roughly flat from $884.8 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $884.8 million in Q4 2025, with the low at $742.7 million in Q3 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $798.5 million across 5 years, with a median of $789.1 million in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 9.27% — and 2025, when it climbed 12.13%.
  • Artivion's Liabilities and Shareholders Equity stood at $762.8 million in 2022, then rose by 3.88% to $792.4 million in 2023, then slipped by 0.42% to $789.1 million in 2024, then rose by 12.13% to $884.8 million in 2025, then retreated by 0.19% to $883.2 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $883.2 million (Q1 2026), $884.8 million (Q4 2025), and $857.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn 46.29 Bn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn 37.13 Bn
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn 10.74 Bn
10 Artivion 978.31 Mn 922.54 Mn 75.45 Mn 883.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 883.16 Mn
Dec 31, 2025 884.80 Mn
Sep 30, 2025 857.66 Mn
Jun 30, 2025 838.39 Mn
Mar 31, 2025 791.16 Mn
Dec 31, 2024 789.10 Mn
Sep 30, 2024 803.14 Mn
Jun 30, 2024 789.54 Mn
Mar 31, 2024 784.01 Mn
Dec 31, 2023 792.40 Mn
Sep 30, 2023 774.79 Mn
Jun 30, 2023 777.86 Mn
Mar 31, 2023 757.07 Mn
Dec 31, 2022 762.80 Mn
Sep 30, 2022 742.73 Mn
Jun 30, 2022 764.86 Mn
Mar 31, 2022 781.86 Mn
Dec 31, 2021 793.05 Mn
Sep 30, 2021 818.65 Mn
Jun 30, 2021 810.50 Mn